Katherine E. Miller
Immunology and Microbiology · The Ohio State University
Publications
660
Citations
227
Est. group size
~1
Recurring co-author estimate
Active years
16
Publishing since 2011
Katherine E. Miller's publication record centers on gynecologic and other cancers, covering topics such as HER2 biomarker testing in endometrial and ovarian cancer, immune profiling of ovarian tumors, clinical trial results, and cancer care delivery issues like patient navigation, genetic testing guidelines, and survivorship programs. The work blends laboratory-adjacent biomarker studies with applied clinical and health-services research relevant to oncology practice. Note that the publication data includes a very large and likely anomalous spike in output for 2024-2025 that may reflect grouped or shared authorship records rather than solely individual output.
Publication counts were low and steady (3-8 per year) from 2017-2023, followed by an extreme and likely data-anomaly-driven surge in 2024-2025 that does not appear to reflect a typical individual research cadence.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Distribution and concordance of HER2 scores in endometrial and ovarian cancer
Gynecologic Oncology · 2025
- Comparison of matching the compound or elements as a differential problem‐solving response
Journal of Applied Behavior Analysis · 2025
- Comparison of breast and gastric HER2 immunohistochemistry scoring criteria in the assessment of endometrial endometrioid adenocarcinoma
Gynecologic Oncology · 2025
- Implementing a technical safety net: A scalable automated quality assurance tool for oncology patient navigation.
JCO Oncology Practice · 2025
- 1122P Phase II open-label multicenter trial of nab-sirolimus + letrozole in advanced/recurrent endometrioid endometrial cancer
Annals of Oncology · 2025
- Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma
Gynecologic Oncology · 2025
- Abstract C130: Evaluation of key performance indicators of a community-focused patient navigation program in an outpatient cancer center
Cancer Epidemiology Biomarkers & Prevention · 2024
- GROWTH OF THE PROGRAM OF ALL-INCLUSIVE CARE FOR THE ELDERLY AND THE ROLE OF PRIVATE EQUITY
Innovation in Aging · 2024
- Germline vs. Somatic Genetic Testing: Their Increasing Use and Application.
PubMed · 2023
- Comparing the predictive value of the surprise question across training levels for estimating twelve-month mortality in gynecologic oncology patients in the outpatient setting (1109)
Gynecologic Oncology · 2023
- Intratumoral expression analysis reveals that OX40 and TIM‑3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancer
Oncology Letters · 2022
- Cost of care in EGFR mutant versus wild-type non-small cell lung cancer.
Journal of Clinical Oncology · 2022
- The rate of venous thromboembolism in patients with non-small cell lung cancer treated with chemotherapy or check point inhibitors.
Journal of Clinical Oncology · 2022
- Telemedicine Use in Disasters: A Scoping Review
Disaster Medicine and Public Health Preparedness · 2021
- Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer
Frontiers in Oncology · 2021
- Gynecologic Oncology×10
- Journal of Clinical Oncology×4
- Clinical Cancer Research×2
- Frontiers in Oncology×2
- Frontiers in Immunology×2
- Elizabeth A.R. Garfinkle
Immunology and Microbiology · The Ohio State University
- Elaine R. Mardis
Immunology and Microbiology · The Ohio State University
- Hakimeh Ebrahimi-Nik
Immunology and Microbiology · The Ohio State University
- Huijuan Song
Immunology and Microbiology · The Ohio State University
- Jay Overholser
Immunology and Microbiology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile